Matthias Schroff, PhD

Chief Scientific Officer

Dr. Matthias Schroff has joined FPG as Chief Scientific Officer to provide guidance on the R&D projects of Ferghana clients and to assess programs of prospects and of counterparties on transactions.

Matthias Schroff is currently the Chief Operating Officer at a clinical-stage biotechnology company developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders. He was the Chief Executive Officer of Vaximm AG and held several positions on management levels at Mologen, starting in R&D, then to Head Scientist, then General Manager, then Chief Operating Officer, and ultimately rising to Chief Executive Officer.

Matthias earned a degree in Biochemistry at the University of Leibniz University Hannover and his Doctorate of Molecular Biology from Freie University Berlin.